Virtus LifeSci Biotech Clinical Trials ETF BBC

Medalist Rating as of | See Virtus Investment Hub

Morningstar’s Analysis BBC

Will BBC outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Virtus LifeSci Biotech Clinical Trls ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BBC

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 14.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Kodiak Sciences Inc

2.08 879,991
Healthcare

AbCellera Biologics Inc Ordinary Shares

1.97 832,094
Healthcare

Xencor Inc

1.51 639,307
Healthcare

Amylyx Pharmaceuticals Inc

1.43 604,432
Healthcare

First Tracks Biotherapeutics Inc

1.41 598,674
Healthcare

MBX Biosciences Inc

1.23 522,845
Healthcare

4D Molecular Therapeutics Inc Ordinary Shares

1.16 491,272
Healthcare

Definium Therapeutics Inc Ordinary Shares

1.13 479,543
Healthcare

SELLAS Life Sciences Group Inc

1.12 475,799
Healthcare

ORIC Pharmaceuticals Inc

1.11 468,330
Healthcare

Sponsor Center